Enliven Therapeutics, Inc. (ELVN): SC 13D/A filed Feb 2, 2024

Form type

SC 13D/A

Filing date

Feb 2, 2024

Accession number

0001104659-24-010043

Filer

Enliven Therapeutics, Inc. (CIK 1672619)